GlaxoSmithKline Pharmaceuticals Limited — Others, 23-07-2025: Copy of Newspaper Publication

GlaxoSmithKline Pharmaceuticals has opened a special window for shareholders with physical shares. This allows re-lodgement of transfer deeds and physical share certificates that were previously rejected or not processed due to document deficiencies, as per a SEBI Circular. This is a crucial opportunity for affected shareholders to complete their share transfers. The facility is available until January 6, 2026, and requests should be submitted to the company's Registrar and Share Transfer Agent, KFin Technologies Ltd. This initiative helps resolve long-pending physical share transfer issues for investors.